Aspen Aerogels (NYSE: ASPN) reported Q3 EPS of ($0.17), $0.11 worse than the analyst estimate of ($0.06). Revenue for the quarter came in at $117.3 million versus the consensus estimate of $107.85 million.

GUIDANCE:

Aspen Aerogels sees FY2024 revenue of $450 million, versus the consensus of $415.2 million.

For earnings history and earnings-related data on Aspen Aerogels (ASPN) click here.